Kestra Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-854
| Closed | -$208K | – | 2824 |
|
|
2025
Q1 | $208K | Sell |
854
-15
| -2% | -$3.65K | ﹤0.01% | 2445 |
|
|
2024
Q4 | $285K | Buy |
869
+1
| +0.1% | +$329 | ﹤0.01% | 2249 |
|
|
2024
Q3 | $290K | Sell |
868
-106
| -11% | -$35.5K | ﹤0.01% | 2110 |
|
|
2024
Q2 | $266K | Sell |
974
-1,144
| -54% | -$312K | ﹤0.01% | 2185 |
|
|
2024
Q1 | $733K | Buy |
2,118
+1,139
| +116% | +$394K | ﹤0.01% | 1429 |
|
|
2023
Q4 | $316K | Sell |
979
-1,002
| -51% | -$324K | ﹤0.01% | 1812 |
|
|
2023
Q3 | $710K | Sell |
1,981
-6
| -0.3% | -$2.15K | 0.01% | 1173 |
|
|
2023
Q2 | $753K | Buy |
1,987
+107
| +6% | +$40.6K | 0.01% | 1109 |
|
|
2023
Q1 | $901K | Sell |
1,880
-1,151
| -38% | -$551K | 0.01% | 992 |
|
|
2022
Q4 | $1.27M | Sell |
3,031
-705
| -19% | -$296K | 0.01% | 944 |
|
|
2022
Q3 | $1.56M | Buy |
3,736
+1,653
| +79% | +$689K | 0.02% | 768 |
|
|
2022
Q2 | $1.03M | Buy |
2,083
+537
| +35% | +$266K | 0.01% | 963 |
|
|
2022
Q1 | $871K | Buy |
1,546
+97
| +7% | +$54.6K | 0.01% | 1024 |
|
|
2021
Q4 | $1.1M | Sell |
1,449
-916
| -39% | -$692K | 0.01% | 939 |
|
|
2021
Q3 | $1.76M | Buy |
2,365
+1,041
| +79% | +$776K | 0.02% | 767 |
|
|
2021
Q2 | $853K | Buy |
1,324
+129
| +11% | +$83.1K | 0.01% | 1017 |
|
|
2021
Q1 | $683K | Buy |
1,195
+509
| +74% | +$291K | 0.01% | 1042 |
|
|
2020
Q4 | $394K | Buy |
686
+682
| +17,050% | +$392K | ﹤0.01% | 1326 |
|
|
2020
Q3 | $337K | Buy |
+4
| New | +$337K | 0.01% | 1053 |
|